ReP USP - Resultado da busca

Artigo de periodico
Neuraminidase is a host‐directed approach to regulate neutrophil responses in sepsis and COVID‐19 (2023)
Formiga, Rodrigo de Oliveira; Amaral, Flávia C.; Souza, Camila F.; Mendes, Daniel A. G. B.; Wanderley, Carlos Wagner de Souza ; Lorenzini, Cristina B.; Santos, Adara A.; Antônia, Juliana; Faria, Lucas F.; Natale, Caio C.; Paula, Nicholas M.; Cunha, Fernando de Queiroz
Source: British Journal of Pharmacology. Unidade: FMRP
Subjects: COVID-19, LIPOPOLISSACARÍDEOS, METALOPROTEINASES, NEUTRÓFILOS, ESPÉCIES REATIVAS DE OXIGÊNIO, SEPSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORMIGA, Rodrigo de Oliveira et al. Neuraminidase is a host‐directed approach to regulate neutrophil responses in sepsis and COVID‐19. British Journal of Pharmacology, v. 180, n. 11, p. 1460-1481, 2023Tradução . . Disponível em: https://doi.org/10.1111/bph.16013. Acesso em: 13 jul. 2024.
APA
Formiga, R. de O., Amaral, F. C., Souza, C. F., Mendes, D. A. G. B., Wanderley, C. W. de S., Lorenzini, C. B., et al. (2023). Neuraminidase is a host‐directed approach to regulate neutrophil responses in sepsis and COVID‐19. British Journal of Pharmacology, 180( 11), 1460-1481. doi:10.1111/bph.16013
NLM
Formiga R de O, Amaral FC, Souza CF, Mendes DAGB, Wanderley CW de S, Lorenzini CB, Santos AA, Antônia J, Faria LF, Natale CC, Paula NM, Cunha F de Q. Neuraminidase is a host‐directed approach to regulate neutrophil responses in sepsis and COVID‐19 [Internet]. British Journal of Pharmacology. 2023 ; 180( 11): 1460-1481.[citado 2024 jul. 13 ] Available from: https://doi.org/10.1111/bph.16013
Vancouver
Formiga R de O, Amaral FC, Souza CF, Mendes DAGB, Wanderley CW de S, Lorenzini CB, Santos AA, Antônia J, Faria LF, Natale CC, Paula NM, Cunha F de Q. Neuraminidase is a host‐directed approach to regulate neutrophil responses in sepsis and COVID‐19 [Internet]. British Journal of Pharmacology. 2023 ; 180( 11): 1460-1481.[citado 2024 jul. 13 ] Available from: https://doi.org/10.1111/bph.16013
Artigo de periodico
Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress (2022)
Silva-Neto, Pedro V. da; Valle, Valéria Beatriz do; Fuzo, Carlos Alessandro; Fernandes, Talita Morais; Toro, Diana Mota; Silva, Thais Fernanda de Campos Fraga da; Basile, Patrícia Adriana; Carvalho, Jonatan Constança Silva de; Pimentel, Vinícius Eduardo; Pérez, Malena Martínez; Oliveira, Camilla Narjara Simão; Rodrigues, Lilian Cataldi ; Bastos, Victor Alexandre Félix; Tella, Sandra de Oliveira Conde; Martins, Ronaldo Bragança; Degiovani, Augusto Marcussi; Ostini, Fátima M.; Feitosa, Marley Ribeiro; Parra, Rogério Serafim; Vilar, Fernando Crivelenti; Gaspar, Gilberto Gambero; Rocha, José Joaquim Ribeiro da ; Féres, Omar; Arruda, Eurico; Maruyama, Sandra R.; Russo, Elisa Maria de Sousa ; Viana, Angelina Lettiere ; Santos, Isabel Kinney Ferreira de Miranda; Bonato, Vânia Luiza Deperon; Cardoso, Cristina Ribeiro de Barros; Tanus-Santos, José Eduardo ; Donadi, Eduardo Antônio; Faccioli, Lucia Helena ; Dias-Baruffi, Marcelo; Fernandes, Ana Paula Morais ; Gerlach, Raquel Fernanda; Sorgi, Carlos Arterio
Source: Biomolecules. Unidades: FORP, FCFRP, FMRP, EERP, FFCLRP
Subjects: METALOPROTEINASES, PEROXIDASE, LIPÍDEOS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA-NETO, Pedro V. da et al. Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress. Biomolecules, v. 12, n. 5, p. 1-20, 2022Tradução . . Disponível em: https://doi.org/10.3390/biom12050604. Acesso em: 13 jul. 2024.
APA
Silva-Neto, P. V. da, Valle, V. B. do, Fuzo, C. A., Fernandes, T. M., Toro, D. M., Silva, T. F. de C. F. da, et al. (2022). Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress. Biomolecules, 12( 5), 1-20. doi:10.3390/biom12050604
NLM
Silva-Neto PV da, Valle VB do, Fuzo CA, Fernandes TM, Toro DM, Silva TF de CF da, Basile PA, Carvalho JCS de, Pimentel VE, Pérez MM, Oliveira CNS, Rodrigues LC, Bastos VAF, Tella S de OC, Martins RB, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, Rocha JJR da, Féres O, Arruda E, Maruyama SR, Russo EM de S, Viana AL, Santos IKF de M, Bonato VLD, Cardoso CR de B, Tanus-Santos JE, Donadi EA, Faccioli LH, Dias-Baruffi M, Fernandes APM, Gerlach RF, Sorgi CA. Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress [Internet]. Biomolecules. 2022 ; 12( 5): 1-20.[citado 2024 jul. 13 ] Available from: https://doi.org/10.3390/biom12050604
Vancouver
Silva-Neto PV da, Valle VB do, Fuzo CA, Fernandes TM, Toro DM, Silva TF de CF da, Basile PA, Carvalho JCS de, Pimentel VE, Pérez MM, Oliveira CNS, Rodrigues LC, Bastos VAF, Tella S de OC, Martins RB, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, Rocha JJR da, Féres O, Arruda E, Maruyama SR, Russo EM de S, Viana AL, Santos IKF de M, Bonato VLD, Cardoso CR de B, Tanus-Santos JE, Donadi EA, Faccioli LH, Dias-Baruffi M, Fernandes APM, Gerlach RF, Sorgi CA. Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress [Internet]. Biomolecules. 2022 ; 12( 5): 1-20.[citado 2024 jul. 13 ] Available from: https://doi.org/10.3390/biom12050604
Artigo de periodico
MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin (2021)
Parente, Juliana Montenegro; Mello, Marcela Maria Blascke de ; Silva, Pedro Henrique Leite da; Omoto, Ana Carolina Mieko ; Pernomian, Laena; Oliveira, Isadora Sousa de; Mahmud, Zabed; Júnior, Rubens Fazan ; Arantes, Eliane Candiani ; Schulz, Richard; Castro, Michele Mazzaron de
Source: Biochemical Pharmacology. Unidades: FMRP, FCFRP
Subjects: HIPERTROFIA VENTRICULAR ESQUERDA, ANTIBIÓTICOS, REGULAÇÃO GÊNICA, HIPERTENSÃO, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARENTE, Juliana Montenegro et al. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin. Biochemical Pharmacology, v. 193, p. 1-13, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2021.114744. Acesso em: 13 jul. 2024.
APA
Parente, J. M., Mello, M. M. B. de, Silva, P. H. L. da, Omoto, A. C. M., Pernomian, L., Oliveira, I. S. de, et al. (2021). MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin. Biochemical Pharmacology, 193, 1-13. doi:10.1016/j.bcp.2021.114744
NLM
Parente JM, Mello MMB de, Silva PHL da, Omoto ACM, Pernomian L, Oliveira IS de, Mahmud Z, Júnior RF, Arantes EC, Schulz R, Castro MM de. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin [Internet]. Biochemical Pharmacology. 2021 ; 193 1-13.[citado 2024 jul. 13 ] Available from: https://doi.org/10.1016/j.bcp.2021.114744
Vancouver
Parente JM, Mello MMB de, Silva PHL da, Omoto ACM, Pernomian L, Oliveira IS de, Mahmud Z, Júnior RF, Arantes EC, Schulz R, Castro MM de. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin [Internet]. Biochemical Pharmacology. 2021 ; 193 1-13.[citado 2024 jul. 13 ] Available from: https://doi.org/10.1016/j.bcp.2021.114744
Artigo de periodico
Nebivolol prevents up-regulation of Nox2/NADPH oxidase and lipoperoxidation in the early stages of ethanol-induced cardiac toxicity (2021)
Vale, Gabriel Tavares do; Silva, Carla Beatriz Pereira da ; Sousa, Arthur Henrique de; Gonzaga, Natália de Almeida; Parente, Juliana Montenegro; Araujo, Katiuscia Martins de; Castro, Michele Mazzaron de; Tirapelli, Carlos Renato
Source: Cardiovascular Toxicology. Unidades: FMRP, EERP
Subjects: ETANOL, ESPÉCIES REATIVAS DE OXIGÊNIO, METALOPROTEINASES, VENTRÍCULO CARDÍACO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALE, Gabriel Tavares do et al. Nebivolol prevents up-regulation of Nox2/NADPH oxidase and lipoperoxidation in the early stages of ethanol-induced cardiac toxicity. Cardiovascular Toxicology, v. 21, n. 3, p. 224-235, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12012-020-09614-1. Acesso em: 13 jul. 2024.
APA
Vale, G. T. do, Silva, C. B. P. da, Sousa, A. H. de, Gonzaga, N. de A., Parente, J. M., Araujo, K. M. de, et al. (2021). Nebivolol prevents up-regulation of Nox2/NADPH oxidase and lipoperoxidation in the early stages of ethanol-induced cardiac toxicity. Cardiovascular Toxicology, 21( 3), 224-235. doi:10.1007/s12012-020-09614-1
NLM
Vale GT do, Silva CBP da, Sousa AH de, Gonzaga N de A, Parente JM, Araujo KM de, Castro MM de, Tirapelli CR. Nebivolol prevents up-regulation of Nox2/NADPH oxidase and lipoperoxidation in the early stages of ethanol-induced cardiac toxicity [Internet]. Cardiovascular Toxicology. 2021 ; 21( 3): 224-235.[citado 2024 jul. 13 ] Available from: https://doi.org/10.1007/s12012-020-09614-1
Vancouver
Vale GT do, Silva CBP da, Sousa AH de, Gonzaga N de A, Parente JM, Araujo KM de, Castro MM de, Tirapelli CR. Nebivolol prevents up-regulation of Nox2/NADPH oxidase and lipoperoxidation in the early stages of ethanol-induced cardiac toxicity [Internet]. Cardiovascular Toxicology. 2021 ; 21( 3): 224-235.[citado 2024 jul. 13 ] Available from: https://doi.org/10.1007/s12012-020-09614-1
Artigo de periodico
Omeprazole induces vascular remodeling by mechanisms involving xanthine oxidoreductase and matrix metalloproteinase activation (2021)
Nogueira, Renato Corrêa; Pinheiro, Lucas Cezar ; Sanches-Lopes, Jessica M.; Parente, Juliana Montenegro; Oliveira-Paula, Gustavo Henrique; Tella, Sandra de Oliveira Conde; Castro, Michele Mazzaron de; Tanus-Santos, José Eduardo
Source: Biochemical Pharmacology. Unidades: EERP, FMRP
Subjects: AORTA, INIBIDORES DE ENZIMAS, REGULAÇÃO GÊNICA, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOGUEIRA, Renato Corrêa et al. Omeprazole induces vascular remodeling by mechanisms involving xanthine oxidoreductase and matrix metalloproteinase activation. Biochemical Pharmacology, v. 190, p. 1-10, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2021.114633. Acesso em: 13 jul. 2024.
APA
Nogueira, R. C., Pinheiro, L. C., Sanches-Lopes, J. M., Parente, J. M., Oliveira-Paula, G. H., Tella, S. de O. C., et al. (2021). Omeprazole induces vascular remodeling by mechanisms involving xanthine oxidoreductase and matrix metalloproteinase activation. Biochemical Pharmacology, 190, 1-10. doi:10.1016/j.bcp.2021.114633
NLM
Nogueira RC, Pinheiro LC, Sanches-Lopes JM, Parente JM, Oliveira-Paula GH, Tella S de OC, Castro MM de, Tanus-Santos JE. Omeprazole induces vascular remodeling by mechanisms involving xanthine oxidoreductase and matrix metalloproteinase activation [Internet]. Biochemical Pharmacology. 2021 ; 190 1-10.[citado 2024 jul. 13 ] Available from: https://doi.org/10.1016/j.bcp.2021.114633
Vancouver
Nogueira RC, Pinheiro LC, Sanches-Lopes JM, Parente JM, Oliveira-Paula GH, Tella S de OC, Castro MM de, Tanus-Santos JE. Omeprazole induces vascular remodeling by mechanisms involving xanthine oxidoreductase and matrix metalloproteinase activation [Internet]. Biochemical Pharmacology. 2021 ; 190 1-10.[citado 2024 jul. 13 ] Available from: https://doi.org/10.1016/j.bcp.2021.114633
Artigo de periodico
Matrix metalloproteinases and arterial hypertension: Role of oxidative stress and nitric oxide in vascular functional and structural alterations (2021)
Prado, Alejandro F.; Batista, Rose Inês Matos ; Tanus-Santos, José Eduardo ; Gerlach, Raquel Fernanda
Source: Biomolecules. Unidades: FMRP, FORP
Subjects: METALOPROTEINASES, HIPERTENSÃO, ESTRESSE OXIDATIVO, ÓXIDO NÍTRICO, FISIOPATOLOGIA, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRADO, Alejandro F. et al. Matrix metalloproteinases and arterial hypertension: Role of oxidative stress and nitric oxide in vascular functional and structural alterations. Biomolecules, v. 11, n. 4, p. 1-17, 2021Tradução . . Disponível em: https://doi.org/10.3390/biom11040585. Acesso em: 13 jul. 2024.
APA
Prado, A. F., Batista, R. I. M., Tanus-Santos, J. E., & Gerlach, R. F. (2021). Matrix metalloproteinases and arterial hypertension: Role of oxidative stress and nitric oxide in vascular functional and structural alterations. Biomolecules, 11( 4), 1-17. doi:10.3390/biom11040585
NLM
Prado AF, Batista RIM, Tanus-Santos JE, Gerlach RF. Matrix metalloproteinases and arterial hypertension: Role of oxidative stress and nitric oxide in vascular functional and structural alterations [Internet]. Biomolecules. 2021 ; 11( 4): 1-17.[citado 2024 jul. 13 ] Available from: https://doi.org/10.3390/biom11040585
Vancouver
Prado AF, Batista RIM, Tanus-Santos JE, Gerlach RF. Matrix metalloproteinases and arterial hypertension: Role of oxidative stress and nitric oxide in vascular functional and structural alterations [Internet]. Biomolecules. 2021 ; 11( 4): 1-17.[citado 2024 jul. 13 ] Available from: https://doi.org/10.3390/biom11040585
Artigo de periodico
TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure (2020)
Mattos, B. R.; Bonacio, G. F.; Vitorino, T. R.; Garcia, V. T.; Amaral, J. H.; Dellalibera-Joviliano, Renata; França, S. C.; Tanus-Santos, José Eduardo ; Rizzi, E.
Source: Biochemical Pharmacology. Unidade: FMRP
Subjects: FARMACOLOGIA, AORTA, PRESSÃO SANGUÍNEA, HIPERTENSÃO, METALOPROTEINASES, ANTAGONISTAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATTOS, B. R. et al. TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure. Biochemical Pharmacology, v. 180, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2020.114121. Acesso em: 13 jul. 2024.
APA
Mattos, B. R., Bonacio, G. F., Vitorino, T. R., Garcia, V. T., Amaral, J. H., Dellalibera-Joviliano, R., et al. (2020). TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure. Biochemical Pharmacology, 180. doi:10.1016/j.bcp.2020.114121
NLM
Mattos BR, Bonacio GF, Vitorino TR, Garcia VT, Amaral JH, Dellalibera-Joviliano R, França SC, Tanus-Santos JE, Rizzi E. TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure [Internet]. Biochemical Pharmacology. 2020 ; 180[citado 2024 jul. 13 ] Available from: https://doi.org/10.1016/j.bcp.2020.114121
Vancouver
Mattos BR, Bonacio GF, Vitorino TR, Garcia VT, Amaral JH, Dellalibera-Joviliano R, França SC, Tanus-Santos JE, Rizzi E. TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure [Internet]. Biochemical Pharmacology. 2020 ; 180[citado 2024 jul. 13 ] Available from: https://doi.org/10.1016/j.bcp.2020.114121

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation